Thöne, Ann-Kathrin http://orcid.org/0000-0003-2082-1757
Dose, Christina http://orcid.org/0000-0001-5405-4934
Junghänel, Michaela http://orcid.org/0000-0002-0846-4948
Hautmann, Christopher
Jendreizik, Lea Teresa http://orcid.org/0000-0003-4312-7645
Treier, Anne-Katrin http://orcid.org/0000-0002-2520-6801
Vetter, Paula
von Wirth, Elena http://orcid.org/0000-0003-2461-4966
Banaschewski, Tobias http://orcid.org/0000-0003-4595-1144
Becker, Katja http://orcid.org/0000-0003-4858-5127
Brandeis, Daniel
Dürrwächter, Ute http://orcid.org/0000-0002-2758-6158
Geissler, Julia http://orcid.org/0000-0003-1878-9647
Hebebrand, Johannes http://orcid.org/0000-0001-5364-6073
Hohmann, Sarah
Holtmann, Martin
Huss, Michael http://orcid.org/0000-0002-1113-8537
Jans, Thomas http://orcid.org/0000-0001-7086-9367
Kaiser, Anna
Ketter, Johanna
Legenbauer, Tanja
Millenet, Sabina
Poustka, Luise http://orcid.org/0000-0002-7738-4394
Renner, Tobias
Romanos, Marcel http://orcid.org/0000-0001-7628-8299
Sandersleben, Henrik Uebel-von
Schneider, Priska S. http://orcid.org/0000-0002-7390-4444
Wenning, Jasmin
Ziegler, Mirjam
Görtz-Dorten, Anja
Döpfner, Manfred http://orcid.org/0000-0002-7929-0463
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01EE1408B)
Universitätsklinikum Köln
Article History
Accepted: 23 January 2023
First Online: 3 March 2023
Declarations
:
: Ethical approval was obtained for the study center Cologne from the University of Cologne (ID 15–216), for the study center Essen from the University of Duisburg-Essen (ID 17–7404-BO), for the study center Hamm from the Ruhr-University Bochum (ID 15–5564), for the study center Göttingen from the University Medical Center Göttingen (ID 3/3/17), for the study center Mainz from the Federal Medical Association of Rhineland-Palatinate (ID 837.237.17 [11071]), for the study center Mannheim from the Ruprecht-Karls-University Heidelberg (ID 2015–646 N-MA), for the study center Marburg from the Philipps-University Marburg (ID Studie 03/16), for the study center Tübingen from the Eberhard-Karls-University Tübingen (ID 791/2015BO2), and for the study center Würzburg from the Julius-Maximilians-University Würzburg (ID 332/15_z).
: <b>A-KTh</b>, <b>AGD</b> and <b>MD</b> were involved in the development of the DISYPS-ILF and will receive royalties from the publisher Hogrefe after publication of this instrument. <b>AGD</b> and <b>MD</b> are AKiP supervisors and lecturers and received income as heads of the School for Child and Adolescent Behavior Therapy at the University of Cologne and royalties from treatment manuals, books, and psychological tests published by Guilford, Hogrefe, Enke, Beltz, and Huber. <b>MD</b> received consulting income and research support from Medice, Shire, and eyelevel. <b>AGD</b> received consulting income and research support from Medice and eyelevel. <b>TB</b> served in an advisory or consultancy role for ADHS digital, Infectopharm, Lundbeck, Medice, Neurim Pharmaceuticals, Oberberg GmbH, Roche, and Takeda. He received conference support or speaker’s fee by Medice and Takeda. He received royalities from Hogrefe, Kohlhammer, CIP Medien, Oxford University Press. <b>KB</b> receives or has received research grants from the German Research Foundation (DFG), German Federal Ministry for Education and Research (BMBF), Philipps-University Marburg, Federal Joint Committee (G-BA), German Ministry for Health, University Hospital Giessen and Marburg and Rhön Klinikum AG. Further she receives royalties and honorary from Georg Thieme Publisher. <b>DB</b> served as an unpaid scientific advisor for an EU-funded neurofeedback trial unrelated to the present work. <b>JG</b> has received a research grant from the Bavarian State Ministry of Family, Labor and Social Affairs. She receives royalties from Hogrefe for the publication of an ADHD treatment manual. <b>MAH</b> served in an advisory role for Shire and Medice and received conference attendance support or was paid for public speaking by Medice, Shire. and Neuroconn. He receives research support from the German Research Foundation and the German Ministry of Education and Research. He receives royalties as Editor-in-Chief of the German Journal for Child and Adolescent Psychiatry and for textbooks from Hogrefe. <b>MIH</b> has served as a member of the advisory boards of Eli Lilly and Co., Engelhardt Arzneimittel, Janssen-Cilag, Medice, Novartis, Shire, and Steiner Arzneimittel within the past five years; served as a consultant to Engelhardt Arzneimittel, Medice, and Steiner Arzneimittel; received honoraria from Eli Lilly and Co., Engelhardt Arzneimittel, Janssen-Cilag, Medice, Novartis, and Shire; and received unrestricted grants for investigator-initiated trials from Eli Lilly and Co., Medice, Engelhardt Arzneimittel, and Steiner Arzneimittel. <b>LP</b> served in an advisory or consultancy role for Shire, Roche, and Infectopharm. She has received speaker’s fees from Shire and royalties from Hogrefe, Kohlhammer, and Schattauer. <b>HUS</b> served in an advisory or consultancy role for Medice. He has received speaker’s fees from Shire and Medice. <b>CD, MJ, CD, CH, LJ, A-KTr, PV, EvW, UD, JH, SH, TJ, AK, JK, TL, SM, TR, MR, PS, JW, MZ</b> are not aware of any biases that might be perceived as affecting the objectivity of this manuscript and declare that they have no competing interests.
: Patients and parents or guardians were informed verbally and received information sheets about the scope and the relevance of the study as well as the study procedures. All participants were able to clarify questions about the study with research staff members. For study participation, patients and their parents or guardians were required to give their assent and informed consent.